AJMC Payer and Specialty Pharmacy Forum: Improving the Adoption of Oncology Biosimilars in Practice
This panel will identify the potential benefits of biosimilars warranting their adoption in clinical practice.
Use of Targeted Mechanisms to Optimize Management of Patients with Acute Myeloid Leukemia (AML)
This virtual symposium will examine evidence from clinical trials data for the incorporation of FLT-3 inhibitors into AML therapy.
Considerations for Novel, Targeted Therapies in the Treatment of Patients with B-Cell Malignancies and Plasma Cell Disorders (On-Demand Webinar)
This webinar will explain the role of the pharmacist in the management of patients with B-cell malignancies and plasma cell disorders in a variety of practice settings.
Safe and Efficacious Use of Immunotherapy Agents: Pharmacist-Driven Strategies to Improve Patient Outcomes (On Demand Webinar)
This session will educate pharmacists about the changing landscape of these agents, including the use of biomarkers to help identify patients most likely to benefit from therapy with immune checkpoint inhibitors.